206 filings
ARS
2023 FY
RGNX
Regenxbio Inc
4 Apr 24
Annual report to shareholders
4:20pm
DEFA14A
RGNX
Regenxbio Inc
4 Apr 24
Additional proxy soliciting materials
4:15pm
DEF 14A
RGNX
Regenxbio Inc
Definitive proxy
4 Apr 24
4:11pm
8-K
RGNX
Regenxbio Inc
11 Mar 24
REGENXBIO Announces Pricing of Upsized Public Offering of Common Stock and Pre-funded Warrants
8:00am
424B5
RGNX
Regenxbio Inc
8 Mar 24
Prospectus supplement for primary offering
6:09am
FWP
asem184 z7p479zpsk
7 Mar 24
Free writing prospectus
6:03am
424B5
5ab6nun6is0m17b6
6 Mar 24
Prospectus supplement for primary offering
4:23pm
S-8
bvv tj3rg
27 Feb 24
Registration of securities for employees
4:54pm
8-K
nd9a33l7hwrd
27 Feb 24
REGENXBIO Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Operational Highlights
4:10pm
8-K
teg1ep
8 Nov 23
REGENXBIO Announces Updated Strategic Plans and Third Quarter 2023 Financial Results
4:10pm
424B5
5od4h
1 Sep 23
Prospectus supplement for primary offering
4:42pm
8-K
uwhc2ddhw59mtd nqeyu
1 Sep 23
Other Events
4:12pm
S-3ASR
mmu 1j54ucs3csi847
4 Aug 23
Automatic shelf registration
4:31pm
8-K
mpb ju29cm8jz5s
2 Aug 23
REGENXBIO Reports Second Quarter 2023 Financial Results and Recent Operational Highlights
4:11pm
8-K
40x3q51mv3pwx65kw
5 Jun 23
Submission of Matters to a Vote of Security Holders
5:15pm
8-K
c3g337a
3 May 23
REGENXBIO Reports First Quarter 2023 Financial Results and Recent Operational Highlights
4:11pm